Navigation Links
Relieving Pain for Diabetes Patients with Neuropathy
Date:12/10/2013

WALTHAM, Mass., Dec. 10, 2013 /PRNewswire/ -- Is there anything more frustrating than waking up in the middle of a nice dream? Awakening in the middle of the night can negatively affect one's mood the next day. It's one thing to be roused by an alarm clock or persistent pet that wants to be fed or walked, but being jolted out of sleep by agonizing leg pain is another story. Unfortunately, many of those who suffer from a condition called Painful Diabetic Neuropathy (PDN) are all too familiar with this occurrence.  

PDN affects many people with diabetes. They might experience burning, stabbing or shooting pains in the feet or legs, especially when trying to sleep. The pain is often so severe it either makes falling sleep impossible or wakes them up.

Luckily, a company called NeuroMetrix, Inc. has recognized the need for a treatment that will work while the patient sleeps. NeuroMetrix is a Waltham, MA-based medical device company that develops and markets tests and therapies for diabetic neuropathies. They have developed the SENSUS™ Pain Management System, an innovative new device to provide relief to those suffering from chronic diabetes pain. As Shai Gozani, President and CEO of NeuroMetrix, reports, "People often describe the pain to be like walking on a bed of nails or feeling like their feet are on fire. SENSUS may help relieve that pain."

One of the best parts about SENSUS is that it's lightweight and discreet. Wrapping around the patient's calf, it can be worn right under clothing. Its easy one-button control makes it the ideal solution for PDN sufferers of any age. It is non-addictive, non-narcotic, free of side effects and provides pain relief even during sleep. SENSUS is also the first transcutaneous electrical nerve stimulator cleared by the U.S. Food and Drug Administration to be used while sleeping. In addition to its pain relief benefits, should SENSUS become dislodged from the skin for any reason, it immediately shuts off.

For more information, visit www.SENSUSRx.com, who paid for the writing and dissemination of this release.

Contact:  Laura Radocaj, Dian Griesel Int'l.
212.825.3210

 


'/>"/>
SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. World Pain Relieving Drug Market 2013-2023
2. Lipitor Lawsuit News: As Lipitor Diabetes Lawsuits Move Forward, Bernstein Liebhard LLP Comments on JAMA Editorial Expressing Concern about the "Statinization" of U.S.
3. Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
4. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
5. Surveyed Endocrinologists Consider Eli Lillys Dulaglutide To Have an Edge Over Competitors for the Treatment of Type 2 Diabetes Patients Who Are Inadequately Controlled On Metformin
6. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
7. Diabetes, Metabolic Syndrome and Cardiovascular Disease
8. How Some People with Diabetes Can Eliminate the Pain of a Daily Procedure
9. Tandem Diabetes Care Announces Closing of Initial Public Offering
10. Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Initial Public Offering of Common Stock
11. Bone-Breaking News: Mayo Clinic Solves Mysterious Link Between Diabetes and Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Research and Markets has announced the addition of the ... (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, ... HIV/AIDS etc.), Forecast to 2022" report to their offering. ... US ... clinical lab testing, which has evolved as a major source ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, ... Symposia Conference, "PI3K Pathways in Immunology, Growth ... (NASDAQ: INFI ) presented ... development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). ... to help overcome resistance to checkpoint inhibition ...
(Date:1/20/2017)... 2017 Research and Markets has announced ... Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company ... ... Hearing Aids Market Sales Volume, Company Analysis and Forecast to ... aid industry. The growing prevalence of hearing impairment ...
Breaking Medicine Technology:
(Date:1/23/2017)... California (PRWEB) , ... January 23, 2017 , ... Old ... principles, has added Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing team ... competing as a bodybuilder in 2012 and in less than a year was able ...
(Date:1/23/2017)... ... , ... “The Inn at the Mill”: a story of love and redemption, hope and ... happy and content. , “The Inn at the Mill” is the creation of published ... Vermont and is now living in Berks County on Crow Hill. The inn, ...
(Date:1/23/2017)... , ... January 23, 2017 , ... “Life Under Blankets”: ... depression from an early age. “Life Under Blankets” is the creation of published author, ... Illinois, Circle Campus in Chicago. She went on to pursue a master’s degree in ...
(Date:1/22/2017)... ... ... Phytocéane invites clients to take an exotic journey deep into the heart ... CREAM. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the coast of ... to create this gentle, velvety body cream to envelop the skin in moisture while ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
Breaking Medicine News(10 mins):